<DOC>
	<DOCNO>NCT00170755</DOCNO>
	<brief_summary>This study evaluate safety , tolerability efficacy darifenacin , long-term treatment adult patient overactive bladder .</brief_summary>
	<brief_title>A Long-Term Safety , Tolerability Efficacy Study Darifenacin Adult Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Adult patient overactive bladder complete previous darifenacin shortterm trial . Patients capable independent toileting able independently complete patient diary . Patients use anticholinergic drug contraindicate Evidence severe liver disease Patients clinically significant urinary gynecological condition Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Overactive Bladder , incontinence , antimuscarinic , darifenacin , long-term treatment</keyword>
</DOC>